- Home
- IKNA vs EDAP Comparison
IKNA vs EDAP Comparison
Compare IKNA & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- EDAP
- Stock Information
- Founded
- IKNA 2016
- EDAP 1979
- Country
- IKNA United States
- EDAP France
- Employees
- IKNA N/A
- EDAP N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IKNA Health Care
- EDAP Health Care
- Exchange
- IKNA Nasdaq
- EDAP Nasdaq
- Market Cap
- IKNA 61.8M
- EDAP 53.8M
- IPO Year
- IKNA 2021
- EDAP 1997
- Fundamental
- Price
- IKNA $1.36
- EDAP $1.70
- Analyst Decision
- IKNA Strong Buy
- EDAP Buy
- Analyst Count
- IKNA 1
- EDAP 3
- Target Price
- IKNA $4.00
- EDAP $8.50
- AVG Volume (30 Days)
- IKNA 95.6K
- EDAP 27.6K
- Earning Date
- IKNA 08-07-2025
- EDAP 05-15-2025
- Dividend Yield
- IKNA N/A
- EDAP N/A
- EPS Growth
- IKNA N/A
- EDAP N/A
- EPS
- IKNA N/A
- EDAP N/A
- Revenue
- IKNA N/A
- EDAP $67,840,467.00
- Revenue This Year
- IKNA N/A
- EDAP N/A
- Revenue Next Year
- IKNA N/A
- EDAP N/A
- P/E Ratio
- IKNA N/A
- EDAP N/A
- Revenue Growth
- IKNA N/A
- EDAP 3.69
- 52 Week Low
- IKNA $0.97
- EDAP $1.26
- 52 Week High
- IKNA $1.94
- EDAP $5.46
- Technical
- Relative Strength Index (RSI)
- IKNA 56.43
- EDAP 40.81
- Support Level
- IKNA $1.10
- EDAP $1.63
- Resistance Level
- IKNA $1.46
- EDAP $1.79
- Average True Range (ATR)
- IKNA 0.07
- EDAP 0.09
- MACD
- IKNA -0.00
- EDAP -0.00
- Stochastic Oscillator
- IKNA 57.58
- EDAP 25.93
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.